Ypsomed has entered into a collaboration with Schott and Lonza to be able to offer the YpsoDose patch injector platform, which is used for the subcutaneous self-administration of high volumes of pharmaceuticals, as a fully integrated solution.   The three partners are cooperating closely to develop all the necessary components and manufacturing processes. This will enable customers to enter into clinical trials quicker with their drugs – often sensitive biopharmaceuticals – and com...